{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1151.25","meta":{"versionId":"3","lastUpdated":"2017-02-16T01:00:02.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Oregon Urology Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-02-16"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2017-02-16"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.25","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1151.25"}],"version":"20170216","name":"BiologicAgentForPatientsUndergoingUrologyCare","title":"Biologic agent for patients undergoing urology care","status":"active","experimental":false,"date":"2017-02-16T01:00:02-05:00","publisher":"Oregon Urology Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Biologic agent for patients undergoing urology care),(Data Element Scope: This data element is to define immunosuppressive therapy in patients undergoing urology care.),(Inclusion Criteria: Patients receiving a bioligic agent),(Exclusion Criteria: Patients not receiving a biologic agent)","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"69509008","display":"Biological agent (product)"}]}]},"expansion":{"identifier":"urn:uuid:94d9f65a-6f7a-41c5-8d34-334a5e83656f","timestamp":"2023-12-10T22:29:40-05:00","total":0}}